Oct 24 (Reuters) - AVI BioPharma Inc (AVII.O) said it will restate financial results from 2004 to 2006 and the first two quarters of 2007 due to reclassification of certain warrants as liabilities, after the U.S. regulators raised questions.
The changes will have a material impact on its previous financial results. However, there will be no effect on cash flows, the drug developer said in a statement. (Reporting by Neha Pathania in Bangalore)
WASHINGTON (Reuters) - Treasury Secretary Timothy Geithner on Wednesday moved to extend the government's $700 billion bailout fund into October 2010 and pledged to deploy no more than $550 billion of it.
The number of U.S. workers in their prime savings years peaks in 2010, affecting a key ratio that has impacted equities for 40 years. If history repeats itself, stocks are set for a funk. Full Article
A couple of firms you've probably never heard of have a few ideas that could revolutionize the broken consumer banking system, says Felix Salmon. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
